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1. ATP bounds substrate with anti-P53 antibody and treated with 2 nM EGFR protein.
2. ATP bound substrate with anti-p53 antibody treated with 2 nM p53 protein.
3. ATP bound substrate with anti-EGFR antibody treated with 2 nM p53 protein. Figure S2a shows the normalised spectra for a range of EGFR concentrations down to 1.25 nM. It can be seen that the shift of peak centre due to EGFR binding has a greater range than for p53 (from 864 cm −1 to 879 cm −1 ). In Figure S1b , the zoomed in region of the forward edge of the peak at 860 cm −1 is displayed, showing the influence of varying protein level on the normalised spectra. 
